Physician profile
Jeff Headrick
NPI 1861496499
$2,426.77
in general payments reported to CMS, 2019-2025
12 companies · $115 in 2025
The $115 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,816 · 2020: $178 · 2021: $30.00 · 2022: $228 · 2023: $60.13 · 2025: $115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $175.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,324.36 | 2019 | |
| Stryker Corporation | $791.85 | 2019-2025 | Mako, Gamma, Hoffmann |
| Depuy Synthes Sales INC. | $98.03 | 2020 | |
| Intellijoint Surgical INC. | $52.71 | 2019 | |
| Heron Therapeutics, INC. | $30.00 | 2021 | |
| Pacira Therapeutics, INC. | $28.69 | 2019 | |
| Microport Orthopedics INC | $23.19 | 2022 | |
| Innovation Technologies INC | $19.90 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $18.80 | 2022 | |
| Amgen INC. | $13.78 | 2022 | |
| Baxter Healthcare | $12.99 | 2022 | |
| Sanofi-Aventis U.S. LLC | $12.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeff Headrick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.